Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

339 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Pembrolizumab and salvage chemotherapy in EGFR T790M-positive non-small-cell lung cancer with high PD-L1 expression.
Tozuka T, Seike M, Minegishi Y, Kitagawa S, Kato T, Takano N, Hisakane K, Takahashi S, Kobayashi K, Kashiwada T, Sugano T, Takeuchi S, Kunugi S, Noro R, Saito Y, Kubota K, Gemma A. Tozuka T, et al. Among authors: takano n. Onco Targets Ther. 2018 Sep 7;11:5601-5605. doi: 10.2147/OTT.S168598. eCollection 2018. Onco Targets Ther. 2018. PMID: 30237726 Free PMC article.
A case of interstitial lung disease with alveolar hemorrhage induced by pembrolizumab.
Sugano T, Seike M, Noro R, Kaburaki S, Tozuka T, Takahashi A, Takano N, Tanaka T, Kashiwada T, Takeuchi S, Minegishi Y, Saito Y, Kubota K, Terasaki Y, Gemma A. Sugano T, et al. Among authors: takano n. Onco Targets Ther. 2018 Sep 17;11:5879-5883. doi: 10.2147/OTT.S169321. eCollection 2018. Onco Targets Ther. 2018. PMID: 30271171 Free PMC article.
Pembrolizumab-induced agranulocytosis in a pulmonary pleomorphic carcinoma patient who developed interstitial lung disease and ocular myasthenia gravis.
Tozuka T, Sugano T, Noro R, Takano N, Hisakane K, Takahashi S, Tanaka T, Kashiwada T, Takeuchi S, Kunugi S, Minegishi Y, Saito Y, Kubota K, Seike M, Gemma A. Tozuka T, et al. Among authors: takano n. Oxf Med Case Reports. 2018 Oct 22;2018(11):omy094. doi: 10.1093/omcr/omy094. eCollection 2018 Nov. Oxf Med Case Reports. 2018. PMID: 30364514 Free PMC article.
Weekly paclitaxel in combination with carboplatin for advanced non-small-cell lung cancer complicated by idiopathic interstitial pneumonias: a single-arm phase II study.
Fukuizumi A, Minegishi Y, Omori M, Atsumi K, Takano N, Hisakane K, Takahashi S, Kobayashi K, Sugano T, Takeuchi S, Noro R, Seike M, Kubota K, Azuma A, Gemma A. Fukuizumi A, et al. Among authors: takano n. Int J Clin Oncol. 2019 Dec;24(12):1543-1548. doi: 10.1007/s10147-019-01516-9. Epub 2019 Jul 27. Int J Clin Oncol. 2019. PMID: 31352631 Clinical Trial.
Immune checkpoint inhibitor-associated interstitial lung diseases correlate with better prognosis in patients with advanced non-small-cell lung cancer.
Sugano T, Seike M, Saito Y, Kashiwada T, Terasaki Y, Takano N, Hisakane K, Takahashi S, Tanaka T, Takeuchi S, Miyanaga A, Minegishi Y, Noro R, Kubota K, Gemma A. Sugano T, et al. Among authors: takano n. Thorac Cancer. 2020 Apr;11(4):1052-1060. doi: 10.1111/1759-7714.13364. Epub 2020 Feb 25. Thorac Cancer. 2020. PMID: 32096610 Free PMC article.
Carboplatin plus nanoparticle albumin-bound paclitaxel for the treatment of thymic carcinoma.
Takahashi A, Noro R, Takano N, Hisakane K, Takahashi S, Fukuizumi A, Omori M, Sugano T, Takeuchi S, Nakamichi S, Miyanaga A, Minegishi Y, Kubota K, Seike M, Gemma A. Takahashi A, et al. Among authors: takano n. Mol Clin Oncol. 2022 Apr;16(4):87. doi: 10.3892/mco.2022.2520. Epub 2022 Feb 21. Mol Clin Oncol. 2022. PMID: 35251638 Free PMC article.
Successful Treatment with Short-Term Steroid Against Severe Hepatitis Confirmed by Liver Biopsy in a Patient with Advanced Squamous-Cell Lung Cancer Receiving a Combination of Pembrolizumab, Carboplatin, and Nab-Paclitaxel: A Case Report.
Hayashi A, Nakamichi S, Nakayama Y, Nagano A, Mikami E, Takano N, Tozuka T, Matsumoto M, Miyanaga A, Noro R, Terasaki Y, Kubota K, Seike M, Gemma A. Hayashi A, et al. Among authors: takano n. Onco Targets Ther. 2022 Jun 7;15:637-642. doi: 10.2147/OTT.S361467. eCollection 2022. Onco Targets Ther. 2022. PMID: 35698605 Free PMC article.
339 results